Active Ingredient
TALC 1%
Nekvnro Wart Remover Patch
FDA Label NDC 84613-052
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Shenzhen Xingqi Technology Co., Ltd. for the product Nekvnro Wart Remover Patch (NDC 84613-052). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient, purpose, uses, warning, dosage and administration, do not use, when using section, stop use, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
Purpose
wart removal
Uses
1, Clean and wipe the skin around the wart.
2, Remove the wart removal tablet, Apply it to the wart,Cover it completely
3, 1 capsule can last for 8-12hours,Recommended 2-3 times a day
Warning
1, external use,Avoid contact with eyes and mouth.
2,If irritation or abnormality occurs, stop using and wash with water
3, Please keep this product out of the reach of children
Dosage And Administration
For external use only.
Do Not Use
1, external use, Avoid contact with eyes and mouth.
2,lf irritation or abnormality occurs, stop using and wash with water
3, Please keep this product out of the reach of children
When Using Section
1, external use,Avoid contact with eyes and mouth.
2,lf irritation or abnormality occurs, stop using and wash with water
3, Please keep this product out of the reach of children
Stop Use
1, external use, Avoid contact with eyes and mouth.
2,lf irritation or abnormality occurs, stop using and wash with water
3, Please keep this product out of the reach of children
Keep Out Of Reach Of Children
Please keep this product out of the reach of children
Inactive Ingredient
POTASSIUM ALUM , SODIUM ALGINATE
Principal Display Panel
Label (Nekvnro 2 9777 1)
* Please review the disclaimer below.
